Search Results

You are looking at 1 - 6 of 6 items for :

  • "Adrenocortical cancer" x
  • Refine by Access: All x
Clear All
Full access

Jonathan R. Strosberg, Gary D. Hammer, and Gerard M. Doherty

Edited by Kerrin G. Robinson

markers and the pathogenesis of adrenocortical cancer . Oncologist 2008 ; 13 : 548 – 561 . 12 Reincke M Karl M Travis WH . p53 mutations in human adrenocortical neoplasms: immunohistochemical and molecular studies . J Clin Endocrinol Metab

Full access

Rachel L. Mitchell, Cory Kosche, Kelly Burgess, Shreya Wadhwa, Lela Buckingham, Ritu Ghai, Jacob Rotmensch, Oleksandra Klapko, and Lydia Usha

Li-Fraumeni syndrome (LFS) is a rare, autosomal dominant disorder that confers a high risk of developing cancer, such as sarcomas and breast, brain, and adrenocortical cancers. In patients with LFS, these cancers are generally diagnosed before 30

Full access

Matthew H. Kulke, Al B. Benson III, Emily Bergsland, Jordan D. Berlin, Lawrence S. Blaszkowsky, Michael A. Choti, Orlo H. Clark, Gerard M. Doherty, James Eason, Lyska Emerson, Paul F. Engstrom, Whitney S. Goldner, Martin J. Heslin, Fouad Kandeel, Pamela L. Kunz, Boris W. Kuvshinoff II, Jeffrey F. Moley, Venu G. Pillarisetty, Leonard Saltz, David E. Schteingart, Manisha H. Shah, Stephen Shibata, Jonathan R. Strosberg, Jean-Nicolas Vauthey, Rebekah White, James C. Yao, Deborah A. Freedman-Cass, and Mary A. Dwyer

and the pathogenesis of adrenocortical cancer . Oncologist 2008 ; 13 : 548 – 561 . 126 Brandi ML Gagel RF Angeli A . Guidelines for diagnosis and therapy of MEN type 1 and type 2 . J Clin Endocrinol Metab 2001 ; 86 : 5658 – 5671

Full access

Jessica S.W. Borgers, Richard P. Tobin, Robert J. Torphy, Victoria M. Vorwald, Robert J. Van Gulick, Carol M. Amato, Dasha T. Cogswell, Tugs-Saikhan Chimed, Kasey L. Couts, Adrie Van Bokhoven, Christopher D. Raeburn, Karl D. Lewis, Joshua Wisell, Martin D. McCarter, Rao R. Mushtaq, and William A. Robinson

failure in adrenocortical cancer: where next? Endocr Connect 2018 ; 7 : E5 – 8 . 30400026 10.1530/EC-18-0398 40. Hino R , Kabashima K , Kato Y , Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant

Full access

Jessica S.W. Borgers, Richard P. Tobin, Robert J. Torphy, Victoria M. Vorwald, Robert J. Van Gulick, Carol M. Amato, Dasha T. Cogswell, Tugs-Saikhan Chimed, Kasey L. Couts, Adrie Van Bokhoven, Christopher D. Raeburn, Karl D. Lewis, Joshua Wisell, Martin D. McCarter, Rao R. Mushtaq, and William A. Robinson

failure in adrenocortical cancer: where next? Endocr Connect 2018 ; 7 : E5 – 8 . 10.1530/EC-18-0398 30400026 40. Hino R , Kabashima K , Kato Y , Tumor cell expression of programmed cell death-1 ligand 1 is a prognostic factor for malignant

Full access

Manisha H. Shah, Whitney S. Goldner, Al B. Benson III, Emily Bergsland, Lawrence S. Blaszkowsky, Pamela Brock, Jennifer Chan, Satya Das, Paxton V. Dickson, Paul Fanta, Thomas Giordano, Thorvardur R. Halfdanarson, Daniel Halperin, Jin He, Anthony Heaney, Martin J. Heslin, Fouad Kandeel, Arash Kardan, Sajid A. Khan, Boris W. Kuvshinoff II, Christopher Lieu, Kimberly Miller, Venu G. Pillarisetty, Diane Reidy, Sarimar Agosto Salgado, Shagufta Shaheen, Heloisa P. Soares, Michael C. Soulen, Jonathan R. Strosberg, Craig R. Sussman, Nikolaos A. Trikalinos, Nataliya A. Uboha, Namrata Vijayvergia, Terence Wong, Beth Lynn, and Cindy Hochstetler

.7326/0003-4819-129-6-199809150-00011 77. Soon PS , McDonald KL , Robinson BG , Molecular markers and the pathogenesis of adrenocortical cancer . Oncologist 2008 ; 13 : 548 – 561 . 18515740 10.1634/theoncologist.2007-0243 78. Brandi ML , Gagel RF , Angeli A